ABBV-552
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABBV-552, covering 2024-04-29 to 2025-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease [Phase 2]